) --

Johnson & Johnson

(JNJ) - Get Report

, the consumer goods and health care company, said fourth-quarter earnings fell 89% to $218 million, or 8 cents a share, after recording a number of litigation and acquisition-related charges.

The company recorded $2.9 billion in after-tax charges for litigation settlements, product liability expenses, costs from the DePuy ASR Hip recall and costs from a planned Synthes acquisition. If these items were excluded, earnings would have been $3.1 billion, or $1.13 a share.

Analysts polled by Thomson Reuters expected

JNJ to earn $1.09 a share on revenue of $16.27 billion


In the prior year, Johnson & Johnson reported fourth-quarter earnings of $1.94 billion, or 70 cents a share.

Johnson & Johnson also said it expects 2012 earnings of between $5.05 and $5.15 a share, excluding special items. Earnings in 2011 were $3.49 a share.

-- Written by Alexandra Zendrian

>To contact the writer of this article, click here:

Alexandra Zendrian

>To submit a news tip, send an email to:


>To follow the writer on Twitter, go to

Alexandra Zendrian